ACM Home Page
Please provide us with feedback. Feedback
Construct anticancer drug-drug correlation network
Full text PdfPdf (574 KB)
Source
Symposium on Applied Computing archive
Proceedings of the 2009 ACM symposium on Applied Computing table of contents
Honolulu, Hawaii
SESSION: Bioinformatics track table of contents
Pages 771-775  
Year of Publication: 2009
ISBN:978-1-60558-166-8
Authors
Jiao Li  Tsinghua University, Beijing, China and Purdue University School of Science, Indianapolis, IN
Pamela Crowell  Idaho State University, Pocatello ID
Jake Yue Chen  Indiana University School of Informatics, Purdue University School of Science, Indianapolis, IN
Sponsor
SIGAPP: ACM Special Interest Group on Applied Computing
Publisher
ACM  New York, NY, USA
Bibliometrics
Downloads (6 Weeks): 15,   Downloads (12 Months): 59,   Citation Count: 0
Additional Information:

abstract   references   index terms   collaborative colleagues  

Tools and Actions: Request Permissions Request Permissions    Review this Article  
DOI Bookmark: Use this link to bookmark this Article: http://doi.acm.org/10.1145/1529282.1529444
What is a DOI?

ABSTRACT

Network biology methods have been promising in linking diseases, genes, and drugs. In this study, we propose a novel computational method to construct drug-drug correlation networks, which consist of drug compounds as network graph nodes and correlated protein-drug profiles above a pre-determined threshold as network graph edges. This computational method is based on extensions of related work on identifying disease-specific proteins within protein-protein sub-networks, and mining protein-drug association profiles from biomedical literature. Our method provides a quantitative framework to compare how each drug compound from one therapeutic area is correlated with other drug compounds in other therapeutic areas, using a drug's protein-drug association profile mined from biomedical literature. We applied this method to the study of drug re-purposing and found that two breast cancer drugs "Mitomycin" and "Bleomycin" may be top drug candidates for treating pancreatic cancers.


REFERENCES

Note: OCR errors may be found in this Reference List extracted from the full text article. ACM has opted to expose the complete List rather than only correct and linked references.

 
1
Imming, P., Sinning, C., and Meyer, A., Drugs, their targets and the nature and number of drug targets. Nature reviews Drug discovery, 2006. 5(10): p. 821--34.
 
2
Yildirim, M. A., et al., Drug-target network. Nature biotechnology, 2007. 25(10): p. 1119--26.
 
3
Goh, K. I., et al., The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(21): p. 8685--8690.
 
4
Hopkins, A. L., Network pharmacology. Nature biotechnology, 2007. 25(10): p. 1110--1.
 
5
O'Connor, K. A. and Roth, B. L., Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nature reviews Drug discovery, 2005. 4(12): p. 1005--14.
 
6
American Cancer Society, Cancer Facts & Figures 2008, Atlanta: American Cancer Society; 2008.
 
7
Laheru, D. and Jaffee, E. M., Immunotherapy for pancreatic cancer - science driving clinical progress. Nature reviews Cancer, 2005. 5(6): p. 459--67.
8
 
9
Chen, J. Y., Shen, C., and Sivachenko, A. Y., Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing, 2006: p. 367--378.
 
10
Hamosh, A., et al., Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic acids research, 2005. 33(Database issue): p. D514--517.
 
11
HAPPI: Human Annotated and Predicted Protein Interaction. http://discern.uits.iu.edu:8340/HAPPI/index.html.
 
12
Li, J., et al. Learning Domain-Specific Knowledge from Context--THUIR at TREC2005 Genomics Track. in Proceedings of 14th Text Retrireval Conference (TREC2005). 2005. Gaithersburg, USA.
 
13
MeSH: Medical Subject Headings (acess 2007). http://www.nlm.nih.gov/mesh/.
 
14
Wu, C. H., et al., The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic acids research, 2006. 34(Database issue): p. D187--91.
 
15
Huan, T., et al., ProteoLens: a visual analytic tool for multi-scale database-driven biological network data mining. BMC Bioinformatics, 2008. 9(Suppl 9): p. S5.
 
16
2008 MEDLINE/PubMed Baseline Data. http://www.nlm.nih.gov/bsd/licensee/2008_stats/baseline_doc.htm l.
 
17
Mitomycin in Clinical Trials. http://clinicaltrials.gov/ct2/show/record/NCT00386399?term=Mit omycins&rank=11.
 
18
Bleomycin in ClinicalTrhials http://clinicaltrials.gov/ct2/show/record/NCT00027521?term=Bleomycin&rank=14.

Collaborative Colleagues:
Jiao Li: colleagues
Pamela Crowell: colleagues
Jake Yue Chen: colleagues